Physician profile
Michael J Stuart
NPI 1215916267
$1,138,561.78
in general payments reported to CMS, 2019-2025
6 companies · $167K in 2025
The $167K reported for 2025 was more than what 98% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $151K · 2020: $131K · 2021: $199K · 2022: $165K · 2023: $127K · 2024: $199K · 2025: $167K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $461K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Education: $5,938 · Grant: $5,938 · Travel and Lodging: $2,105 · Food and Beverage: $1,017.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $460,744.66 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,383.18 |
| Education | $5,937.50 |
| Grant | $5,937.50 |
| Travel and Lodging | $2,105.37 |
| Food and Beverage | $1,016.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,125,068.69 | 2019-2025 | Arthrex, Knee & Hip Implants Meniscal Repair Fiberstitch |
| Smith+Nephew, INC. | $11,888.24 | 2023-2024 | Q-Fix |
| Stryker Corporation | $1,049.84 | 2019-2024 | Aequalis Ascend Flex, Augment Injectable, Axsos |
| Gemini Medical LLC | $230.28 | 2019-2021 | |
| Depuy Synthes Sales INC. | $210.27 | 2022 | |
| Foundation Medical, LLC | $114.46 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Stuart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.